• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺炎克雷伯菌临床分离株泛耐药的基因组途径。

Genomic path to pandrug resistance in a clinical isolate of Klebsiella pneumoniae.

机构信息

Servicio de Microbiología, Hospital Universitario La Paz, IdiPaz, Paseo de La Castellana 261, 28046 Madrid, Spain.

Servicio de Hepatología y Trasplante Hepático Infantil, Hospital Universitario La Paz, Paseo de La Castellana 261, 28046 Madrid, Spain.

出版信息

Int J Antimicrob Agents. 2018 Nov;52(5):713-718. doi: 10.1016/j.ijantimicag.2018.08.012. Epub 2018 Aug 23.

DOI:10.1016/j.ijantimicag.2018.08.012
PMID:30144503
Abstract

Carbapenem-resistant Klebsiella pneumoniae have spread globally throughout tertiary hospitals. Many Carbapenem-resistant K. pneumoniae clinical isolates are multidrug-resistant (MDR) and may become eventually pandrug-resistant (PDR). Here we present the closed genome of a PDR VIM-1-producing K. pneumoniae strain (KP1050) obtained in a tertiary hospital. The isolate belonged to sequence type 54 (ST54) and had five extrachromosomal elements (four plasmids and a circular phage genome). Most of the antimicrobial resistance genes (ARGs) were located in two clusters borne by two of the plasmids, comprising a class 1 integron that contained up to 14 ARGs including a VIM-1 metallo-β-lactamase gene, and an IS26 transposon that contained a mobile element from Acinetobacter baumannii encoding the amikacin resistance gene aac(6')-Ian. A MDR isolate obtained 6 years previously was identified (KP1048) retrospectively and was sequenced. Comparison of the two genomes showed that chromosomal mutations in outer membrane porins as well as mutations in the ramR and phoQ genes contributed to increase the resistance spectrum.

摘要

产碳青霉烯酶肺炎克雷伯菌已在全球各三级医院中广泛传播。许多产碳青霉烯酶肺炎克雷伯菌临床分离株为多重耐药(MDR),并可能最终成为泛耐药(PDR)。在此,我们报告了一株产 VIM-1 型碳青霉烯酶 PDR 肺炎克雷伯菌(KP1050)的全基因组序列,该菌株从一家三级医院中获得。该分离株属于序列型 54(ST54),并带有五个染色体外元件(四个质粒和一个环状噬菌体基因组)。大多数抗菌药物耐药基因(ARGs)位于两个质粒上的两个簇中,包括一个含有多达 14 个 ARGs 的 1 类整合子,其中包括一个 VIM-1 金属β-内酰胺酶基因,以及一个含有来自鲍曼不动杆菌的可移动元件的 IS26 转座子,该元件编码阿米卡星耐药基因 aac(6')-Ian。我们回顾性地鉴定并测序了 6 年前获得的一个 MDR 分离株(KP1048)。对这两个基因组的比较表明,外膜孔蛋白的染色体突变以及 ramR 和 phoQ 基因的突变有助于增加耐药谱。

相似文献

1
Genomic path to pandrug resistance in a clinical isolate of Klebsiella pneumoniae.肺炎克雷伯菌临床分离株泛耐药的基因组途径。
Int J Antimicrob Agents. 2018 Nov;52(5):713-718. doi: 10.1016/j.ijantimicag.2018.08.012. Epub 2018 Aug 23.
2
Emergence of co-existence of bla with rmtC and qnrB genes in clinical carbapenem-resistant Klebsiella pneumoniae isolates in burning center from southeast of Iran.伊朗东南部烧伤中心临床耐碳青霉烯肺炎克雷伯菌分离株中bla与rmtC和qnrB基因共存情况的出现
Folia Microbiol (Praha). 2019 Jan;64(1):55-62. doi: 10.1007/s12223-018-0630-3. Epub 2018 Jul 12.
3
Molecular analysis of clinical isolates of ceftazidime-avibactam-resistant Klebsiella pneumoniae.头孢他啶-阿维巴坦耐药肺炎克雷伯菌临床分离株的分子分析。
Clin Microbiol Infect. 2021 Jul;27(7):1040.e1-1040.e6. doi: 10.1016/j.cmi.2021.03.001. Epub 2021 Mar 26.
4
Co-occurrence of a novel VIM-1 and FosA3-encoding multidrug-resistant plasmid and a KPC-2-encoding pKP048-like plasmid in a clinical isolate of Klebsiella pneumoniae sequence type 11.肺炎克雷伯菌 11 型临床分离株中同时存在新型 VIM-1 和 FosA3 编码的多药耐药质粒以及 KPC-2 编码的 pKP048 样质粒
Infect Genet Evol. 2020 Nov;85:104479. doi: 10.1016/j.meegid.2020.104479. Epub 2020 Jul 27.
5
Multi-drug carbapenem-resistant Klebsiella pneumoniae infection carrying the OXA-48 gene and showing variations in outer membrane protein 36 causing an outbreak in a tertiary care hospital in Riyadh, Saudi Arabia.携带OXA - 48基因且外膜蛋白36发生变异的耐多药碳青霉烯类肺炎克雷伯菌感染,在沙特阿拉伯利雅得一家三级医疗医院引发了疫情。
Int J Infect Dis. 2014 Nov;28:186-92. doi: 10.1016/j.ijid.2014.05.021. Epub 2014 Sep 19.
6
A Polyclonal Spread Emerged: Characteristics of Carbapenem-Resistant Isolates from the Intensive Care Unit in a Chinese Tertiary Hospital.多克隆传播出现:中国一家三甲医院重症监护病房耐碳青霉烯类分离株的特征。
Pol J Microbiol. 2020 Sep;69(3):311-319. doi: 10.33073/pjm-2020-034. Epub 2020 Sep 8.
7
Outbreak by Hypermucoviscous ST11 Isolates with Carbapenem Resistance in a Tertiary Hospital in China.中国一家三级医院中具有碳青霉烯类耐药性的高黏液性 ST11 分离株引起的暴发。
Front Cell Infect Microbiol. 2017 May 16;7:182. doi: 10.3389/fcimb.2017.00182. eCollection 2017.
8
Whole genome sequencing characterization of Slovenian carbapenem-resistant Klebsiella pneumoniae, including OXA-48 and NDM-1 producing outbreak isolates.斯洛文尼亚产碳青霉烯酶肺炎克雷伯菌(包括产 OXA-48 和 NDM-1 的爆发株)的全基因组测序特征分析。
PLoS One. 2020 Apr 13;15(4):e0231503. doi: 10.1371/journal.pone.0231503. eCollection 2020.
9
Molecular characterization of carbapenem-resistant strains of Klebsiella pneumoniae isolated from Iranian patients: first identification of blaKPC gene in Iran.从伊朗患者中分离出的耐碳青霉烯肺炎克雷伯菌菌株的分子特征:伊朗首次鉴定出blaKPC基因
Microb Drug Resist. 2014 Aug;20(4):285-93. doi: 10.1089/mdr.2013.0074. Epub 2014 Jan 15.
10
A multicenter study of β-lactamase-producing Klebsiella pneumoniae isolated from university teaching hospitals of Urmia, Iran.对从伊朗乌尔米亚大学教学医院分离出的产β-内酰胺酶肺炎克雷伯菌进行的多中心研究。
J Infect Dev Ctries. 2019 Aug 31;13(8):690-697. doi: 10.3855/jidc.9985.

引用本文的文献

1
From genomics to treatment: overcoming pan-drug-resistant in clinical settings.从基因组学到治疗:克服临床环境中的泛耐药性
Front Pharmacol. 2025 May 30;16:1570278. doi: 10.3389/fphar.2025.1570278. eCollection 2025.
2
The A226D Mutation of OmpC Leads to Increased Susceptibility to β-Lactam Antibiotics in .OmpC的A226D突变导致对β-内酰胺类抗生素的敏感性增加。 (原文句末不完整,推测补充完整后的译文)
Biology (Basel). 2024 Aug 9;13(8):600. doi: 10.3390/biology13080600.
3
Screening of MMV pandemic response and pathogen box compounds against pan-drug-resistant to identify potent inhibitory compounds.
筛选MMV大流行应对药物和病原体盒式化合物以对抗泛耐药性,从而鉴定出有效的抑制性化合物。
New Microbes New Infect. 2023 Nov 7;55:101193. doi: 10.1016/j.nmni.2023.101193. eCollection 2023 Oct.
4
Unveiling the genome of a high-risk pandrug-resistant Klebsiella pneumoniae emerging in the Brazilian Amazon Region, 2022.揭示 2022 年在巴西亚马逊地区出现的高风险泛耐药肺炎克雷伯菌的基因组。
Mem Inst Oswaldo Cruz. 2023 Oct 27;118:e230081. doi: 10.1590/0074-02760230081. eCollection 2023.
5
Carbapenemase-Producing in COVID-19 Intensive Care Patients: Identification of IncL-VIM-1 Plasmid in Previously Non-Predominant Sequence Types.新冠重症监护患者中产碳青霉烯酶情况:在既往非优势序列类型中鉴定IncL-VIM-1质粒
Antibiotics (Basel). 2023 Jan 6;12(1):107. doi: 10.3390/antibiotics12010107.
6
Genomic evolution of the globally disseminated multidrug-resistant clonal group 147.全球传播的多药耐药克隆群 147 的基因组进化。
Microb Genom. 2022 Jan;8(1). doi: 10.1099/mgen.0.000737.
7
Evolution of the Gram-Negative Antibiotic Resistance Spiral over Time: A Time-Series Analysis.革兰氏阴性菌抗生素耐药性随时间的演变:一项时间序列分析
Antibiotics (Basel). 2021 Jun 17;10(6):734. doi: 10.3390/antibiotics10060734.
8
Evolution of VIM-1-Producing Klebsiella pneumoniae Isolates from a Hospital Outbreak Reveals the Genetic Bases of the Loss of the Urease-Positive Identification Character.从医院暴发中分离出的产VIM-1型肺炎克雷伯菌的进化揭示了脲酶阳性鉴定特征丧失的遗传基础。
mSystems. 2021 Jun 29;6(3):e0024421. doi: 10.1128/mSystems.00244-21. Epub 2021 Jun 1.
9
Isolation and Characterization of Novel Lytic Bacteriophages Infecting Epidemic Carbapenem-Resistant Strains.感染流行碳青霉烯耐药菌株的新型裂解性噬菌体的分离与鉴定
Front Microbiol. 2020 Jul 21;11:1554. doi: 10.3389/fmicb.2020.01554. eCollection 2020.
10
Characterization of Extremely Drug-Resistant and Hypervirulent AB030.极耐药和高毒力AB030的特性分析
Antibiotics (Basel). 2020 Jun 17;9(6):328. doi: 10.3390/antibiotics9060328.